
Role at ANSTO
Nick is a radiation biologist who works for the NST Human Health research theme.
Showing 221 - 240 of 241 results
Nick is a radiation biologist who works for the NST Human Health research theme.
Whilst at ANSTO’s Australian Synchrotron today, Prime Minister Scott Morrison announced new funding for the Australian Precision Medicine Enterprise (APME) Project. The Australian Government will contribute $23m in grant funding under the Manufacturing Collaboration Stream of the Modern Manufacturing Initiative (MMI) towards the $71.2m project.
Recent catastrophic Australian bushfires produced extremely high levels of fine particle pollution.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.
Close to 3000 members of the public decided to have a look at a building that is shaped like a doughnut, is as big as a football field and creates light more powerful than the sun when the Australian Synchrotron held its bi-annual Open Day held on Sunday, 16 October.
An international team of academic researchers led by Curtin University have provided a description of a new species of pterosaur, a flying reptile.
Retrieving an Antarctic ice core more than a million years old presents challenges and opportunities.
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,
Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub
Study shows for the first time that vegetation in the Windmill Islands, East Antarctica is changing rapidly in response to a drying climate.
Australian-first detector to accelerate cancer research unveiled.
The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.
Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.
Archive of ANSTO research publications, seminars and short talks.